Committee for Medicinal Products for Human Use (chmp) Guideline on Follow-up of Patients Administered with Gene Therapy Medicinal Products Agreed by Gene Therapy

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE CLINICAL INVESTIGATIONS OF MEDICINAL PRODUCTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION AGREED BY EFFICACY WORKING PARTY November 2008 ADOPTION BY CHMP FOR RELEASE FOR CONSULTATION

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT GUIDELINE ON MEDICINAL PRODUCTS FOR THE TREATMENT OF ALZHEIMER’S DISEASE AND OTHER DEMENTIAS DRAFT AGREED BY THE EFFICACY WORKING PARTY April – June 2007 ADOPTION BY CHMP FOR RELEASE FOR CONSULTATION

Committee for Medicinal Products for Human Use (chmp) Draft Guideline on the Evaluation of Anticancer Medicinal Products in Man

Committee for Medicinal Products for Human Use (chmp) Guideline on the Investigation of Manufacturing Processes for Plasma-derived Medicinal Products with Regard to Vcjd Risk

Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact © European Medicines Agency, 2014. Reproduction is authorised provided the source is acknowledged. 20 November 2014 EMA/CHMP/ CVMP/ SWP/169430/2012 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterina...